Zydus gets US FDA nod to market generic antifungal medication
Zydus Worldwide DMCC has received final approval from the US Food and Drug Administration (FDA) to market the product
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
US FDA nod
Regrow Biosciences gets US FDA nod for phase-II trials of Ossgrow for Osteonecrosis in US
The company moves one-step closer to attain a global market monopoly estimated at $5 billion through this feat